-
1
-
-
14844295975
-
Improving arteriovenous fistula construction: Fistula first initiative
-
Besarab A, Brouwer D. Improving arteriovenous fistula construction: fistula first initiative. Hemodialysis Int 2004; 8: 199-206.
-
(2004)
Hemodialysis Int.
, vol.8
, pp. 199-206
-
-
Besarab, A.1
Brouwer, D.2
-
2
-
-
0028833101
-
Are clinical signs accurate indicators of the cause of central venous catheter occlusion?
-
Stephens L, Haire W, Kotulak G. Are clinical signs accurate indicators of the cause of central venous catheter occlusion? JPEN 1995; 19: 75-9.
-
(1995)
JPEN
, vol.19
, pp. 75-79
-
-
Stephens, L.1
Haire, W.2
Kotulak, G.3
-
3
-
-
0012373123
-
Vascular access for hemodialysis
-
Daugirdas JT, Blake PG, Ing RS, eds. 3rd edition. Philadelphia: Lippincott Williams & Wilkins
-
Besarab A, Raja RM. Vascular access for hemodialysis. In: Daugirdas JT, Blake PG, Ing RS, eds. Handbook of dialysis, 3rd edition. Philadelphia: Lippincott Williams & Wilkins 2001; 67-101.
-
(2001)
Handbook of Dialysis
, pp. 67-101
-
-
Besarab, A.1
Raja, R.M.2
-
4
-
-
0036684535
-
Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis
-
Eyrich H, Walton T, Macon E, Howe A. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis. Am J Health-Syst Pharm 2002; 59: 1437-40.
-
(2002)
Am. J. Health-Syst Pharm.
, vol.59
, pp. 1437-1440
-
-
Eyrich, H.1
Walton, T.2
Macon, E.3
Howe, A.4
-
5
-
-
0035149994
-
K/DOQI clinical practice guidelines for vascular access
-
National Kidney Foundation. 2000
-
National Kidney Foundation. K/DOQI clinical practice guidelines for vascular access 2000. Am J Kidney Dis 2001; 37 (suppl 1): S139-81.
-
(2001)
Am. J. Kidney Dis.
, vol.37
, Issue.SUPPL. 1
-
-
-
6
-
-
0034209664
-
Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices
-
Davis S, Vermeulen L, Banton J, Schwartz B, Williams E. Activity and dosage of alteplase dilution for clearing occlusions of venous-access devices, Am J Health-Sys Pharm 2000; 57: 1039-45.
-
(2000)
Am. J. Health-Sys Pharm
, vol.57
, pp. 1039-1045
-
-
Davis, S.1
Vermeulen, L.2
Banton, J.3
Schwartz, B.4
Williams, E.5
-
7
-
-
0035523074
-
Catheter thrombosis
-
Beathard G. Catheter thrombosis. Semin Dial 2001; 14: 144-5.
-
(2001)
Semin Dial
, vol.14
, pp. 144-145
-
-
Beathard, G.1
-
8
-
-
0036534305
-
Safe and cost effective use of alteplase for the clearance of occluded central venous access devices
-
Timoney J, Malkin M, Leone D, et al. Safe and cost effective use of alteplase for the clearance of occluded central venous access devices. J Clin.Oncol 2002; 20: 1918-22.
-
(2002)
J Clin.Oncol
, vol.20
, pp. 1918-1922
-
-
Timoney, J.1
Malkin, M.2
Leone, D.3
-
9
-
-
0027258712
-
Use of tissue plasminogen activator for reopening of clotted dialysis catheters
-
Paulsen D, Reisoether A, Aasen M, Fauchald P. Use of tissue plasminogen activator for reopening of clotted dialysis catheters. Nephron 1993; 64: 468-70.
-
(1993)
Nephron
, vol.64
, pp. 468-470
-
-
Paulsen, D.1
Reisoether, A.2
Aasen, M.3
Fauchald, P.4
-
10
-
-
0035187268
-
Low-dose tPA for hemodialysis catheter clearance
-
Spry L, Miller G. Low-dose tPA for hemodialysis catheter clearance. Dial Transplant 2001; 30: 10-3.
-
(2001)
Dial Transplant
, vol.30
, pp. 10-13
-
-
Spry, L.1
Miller, G.2
-
11
-
-
0034877251
-
Recombinant tissue plasminogen activator (Alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial - The cardiovascular thrombolytic to open occluded lines (COOL) efficacy trial
-
Ponec D, Irwin D, Haire W, et al. Recombinant tissue plasminogen activator (Alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial - the cardiovascular thrombolytic to open occluded lines (COOL) efficacy trial. J Vasc Interv Radiol 2001; 12: 951-5.
-
(2001)
J. Vasc. Interv. Radiol.
, vol.12
, pp. 951-955
-
-
Ponec, D.1
Irwin, D.2
Haire, W.3
-
12
-
-
0034921944
-
Thrombolysis for restoration of patency to haemodialysis central venous catheters: A systematic review
-
Clase C, Crowther M, Ingram A, Cina C. Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review. J Thromb Thrombolysis 2001; 11: 127-36.
-
(2001)
J. Thromb. Thrombolysis
, vol.11
, pp. 127-136
-
-
Clase, C.1
Crowther, M.2
Ingram, A.3
Cina, C.4
-
13
-
-
1642534357
-
Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL
-
Fink J, Capozzi D, Shermock K, et al. Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL. Ann Pharmacother 2004; 38: 351-2.
-
(2004)
Ann. Pharmacother.
, vol.38
, pp. 351-352
-
-
Fink, J.1
Capozzi, D.2
Shermock, K.3
-
15
-
-
21644472484
-
Short and long alteplase dwells in dysfunctional hemodialysis catheters
-
MacRae JM, Loh G, Djurdjeb O, et al. Short and long alteplase dwells in dysfunctional hemodialysis catheters. Hemodialysis Int 2005; 9: 189-95.
-
(2005)
Hemodialysis Int.
, vol.9
, pp. 189-195
-
-
MacRae, J.M.1
Loh, G.2
Djurdjeb, O.3
-
16
-
-
8344245223
-
Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis
-
Nguyen T, Dikun M. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis. Am J Health-Syst Pharm 2004; 61: 1922-4.
-
(2004)
Am. J. Health-Syst Pharm.
, vol.61
, pp. 1922-1924
-
-
Nguyen, T.1
Dikun, M.2
-
17
-
-
0036141026
-
A longitudinal study of the repeated use of alteplase as therapy for tunnelled hemodialysis catheter dysfunction 17
-
Little M, Walshe J. A longitudinal study of the repeated use of alteplase as therapy for tunnelled hemodialysis catheter dysfunction. Am J Kidney Dis 2002; 39: 1-15.
-
(2002)
Am. J. Kidney Dis.
, vol.39
, pp. 1-15
-
-
Little, M.1
Walshe, J.2
|